Budget Amount *help |
¥19,240,000 (Direct Cost: ¥14,800,000、Indirect Cost: ¥4,440,000)
Fiscal Year 2010: ¥6,240,000 (Direct Cost: ¥4,800,000、Indirect Cost: ¥1,440,000)
Fiscal Year 2009: ¥6,240,000 (Direct Cost: ¥4,800,000、Indirect Cost: ¥1,440,000)
Fiscal Year 2008: ¥6,760,000 (Direct Cost: ¥5,200,000、Indirect Cost: ¥1,560,000)
|
Research Abstract |
We identified risk factors for surgical failure of trabeculectomy, a major surgery for glaucoma patients. In open-glaucoma patients, previous cataract surgery is a significant risk factor for the surgical failure while previous cataract surgery and granulomatous uveitis-type are risk factors in uveitic glaucoma patients. An anti-VEGF drug, bevacizumab, reduces surgical complications, and improves the short-term surgical success of trabeculectomy.
|